176 related articles for article (PubMed ID: 33757927)
1. [What's new in the management of endometrial cancer? Update on the new European recommendations for 2021].
Azaïs H; Lecointre L; Canlorbe G;
Gynecol Obstet Fertil Senol; 2021 Sep; 49(9):691-697. PubMed ID: 33757927
[TBL] [Abstract][Full Text] [Related]
2. [Application in France of the 2021 European recommendations on endometrial cancer].
Deluche E; Marti C; Jochum F; Bendifallah S; Azaïs H; Deidier J; Cockenpot V; Menoux I; Kissel M; Balaya V; Betrian S; Mathevet P; Chargari C; Gouy S; Genestie C; Uzan C; Devouassoux-Shisheboran M; Guyon F; Akladios C; Body N; Guani B;
Bull Cancer; 2023 Jan; 110(1):55-68. PubMed ID: 36462971
[TBL] [Abstract][Full Text] [Related]
3. [European guidelines (ESMO-ESGO-ESTRO consensus conference) for the management of endometrial cancer].
Ballester M; Bendifallah S; Daraï E
Bull Cancer; 2017 Dec; 104(12):1032-1038. PubMed ID: 29173977
[TBL] [Abstract][Full Text] [Related]
4. Sentinel Lymph Node Mapping in Endometrial Cancer: An Update.
Khoury-Collado F; St Clair C; Abu-Rustum NR
Oncologist; 2016 Apr; 21(4):461-6. PubMed ID: 26961924
[TBL] [Abstract][Full Text] [Related]
5. [Evolution of endometrial cancer surgery].
Canlorbe G; Nikpayam M; Belghiti J
Rev Prat; 2022 Sep; 72(7):738-741. PubMed ID: 36511959
[TBL] [Abstract][Full Text] [Related]
6. Sentinel lymph node mapping and staging in endometrial cancer: A Society of Gynecologic Oncology literature review with consensus recommendations.
Holloway RW; Abu-Rustum NR; Backes FJ; Boggess JF; Gotlieb WH; Jeffrey Lowery W; Rossi EC; Tanner EJ; Wolsky RJ
Gynecol Oncol; 2017 Aug; 146(2):405-415. PubMed ID: 28566221
[TBL] [Abstract][Full Text] [Related]
7. Endometrial cancer risk factors, treatment, and survival outcomes as per the European Society for Medical Oncology (ESMO) - European Society of Gynaecological Oncology (ESGO) - European Society for Radiotherapy and Oncology (ESTRO) risk groups and International Federation of Gynecology and Obstetrics (FIGO) staging: An experience from developing world.
Gupta N; Pandey A; Dimri K; Sehgal A; Bhagat R; Suraj ; Gill G
J Cancer Res Ther; 2023; 19(3):701-707. PubMed ID: 37470597
[TBL] [Abstract][Full Text] [Related]
8. A comparison of sentinel lymph node biopsy to lymphadenectomy for endometrial cancer staging (FIRES trial): a multicentre, prospective, cohort study.
Rossi EC; Kowalski LD; Scalici J; Cantrell L; Schuler K; Hanna RK; Method M; Ade M; Ivanova A; Boggess JF
Lancet Oncol; 2017 Mar; 18(3):384-392. PubMed ID: 28159465
[TBL] [Abstract][Full Text] [Related]
9. Sentinel lymph node biopsy in early stage endometrial cancer: a Turkish gynecologic oncology group study (TRSGO-SLN-001).
Taşkın S; Altin D; Vatansever D; Tokgozoglu N; Karabük E; Turan H; Takmaz Ö; Kahramanoglu I; Naki MM; Güngör M; Köse F; Ortac F; Arvas M; Ayhan A; Taskiran C
Int J Gynecol Cancer; 2020 Mar; 30(3):299-304. PubMed ID: 31857440
[TBL] [Abstract][Full Text] [Related]
10. From systematic lymphadenectomy to sentinel lymph node mapping: a review on transitions and current practices in endometrial cancer staging.
Stämpfli CAL; Papadia A; Mueller MD
Chin Clin Oncol; 2021 Apr; 10(2):22. PubMed ID: 33951918
[TBL] [Abstract][Full Text] [Related]
11. The safety and feasibility of minimally invasive sentinel lymph node staging using indocyanine green in the management of endometrial cancer.
Mendivil AA; Abaid LN; Brown JV; Mori KM; Beck TL; Epstein HD; Micha JP; Goldstein BH
Eur J Obstet Gynecol Reprod Biol; 2018 May; 224():29-32. PubMed ID: 29529474
[TBL] [Abstract][Full Text] [Related]
12. [Primary management of endometrial carcinoma. Joint recommendations of the French society of gynecologic oncology (SFOG) and of the French college of obstetricians and gynecologists (CNGOF)].
Querleu D; Darai E; Lecuru F; Rafii A; Chereau E; Collinet P; Crochet P; Marret H; Mery E; Thomas L; Villefranque V; Floquet A; Planchamp F
Gynecol Obstet Fertil Senol; 2017 Dec; 45(12):715-725. PubMed ID: 29132772
[TBL] [Abstract][Full Text] [Related]
13. Current landscape and future perspective of sentinel node mapping in endometrial cancer.
Bogani G; Raspagliesi F; Leone Roberti Maggiore U; Mariani A
J Gynecol Oncol; 2018 Nov; 29(6):e94. PubMed ID: 30207102
[TBL] [Abstract][Full Text] [Related]
14. A prospective investigation of fluorescence imaging to detect sentinel lymph nodes at robotic-assisted endometrial cancer staging.
Paley PJ; Veljovich DS; Press JZ; Isacson C; Pizer E; Shah C
Am J Obstet Gynecol; 2016 Jul; 215(1):117.e1-7. PubMed ID: 26743505
[TBL] [Abstract][Full Text] [Related]
15. The Advantage of Pinpoint Camera System With Indocyanine Green for Sentinel Lymph Node Micrometastasis Detection in Low Risk Endometrial Cancer.
Lazaridis A; Kogeorgos S; Balinakos P; Pavlakis K; Gavresea T; Pistofidis G
In Vivo; 2021; 35(2):1033-1039. PubMed ID: 33622899
[TBL] [Abstract][Full Text] [Related]
16. Concordance between preoperative ESMO-ESGO-ESTRO risk classification and final histology in early-stage endometrial cancer.
Daix M; Angeles MA; Migliorelli F; Kakkos A; Martinez Gomez C; Delbecque K; Mery E; Tock S; Gabiache E; Decuypere M; Goffin F; Martinez A; Ferron G; Kridelka F
J Gynecol Oncol; 2021 Jul; 32(4):e48. PubMed ID: 33908709
[TBL] [Abstract][Full Text] [Related]
17. Sentinel lymph node biopsy with cervical injection of indocyanine green in apparent early-stage endometrial cancer: predictors of unsuccessful mapping.
Tortorella L; Casarin J; Multinu F; Cappuccio S; McGree ME; Weaver AL; Langstraat CL; Keeney GL; Kumar A; Melis GB; Angioni S; Scambia G; Mariani A; Glaser GE
Gynecol Oncol; 2019 Oct; 155(1):34-38. PubMed ID: 31402166
[TBL] [Abstract][Full Text] [Related]
18. Sentinel Node Mapping Using Indocyanine Green and Near-infrared Fluorescence Imaging Technology for Uterine Malignancies: Preliminary Experience With the Da Vinci Xi System.
Siesto G; Romano F; Fiamengo B; Vitobello D
J Minim Invasive Gynecol; 2016; 23(4):470-1. PubMed ID: 26767824
[TBL] [Abstract][Full Text] [Related]
19. Indocyanine green fluorescence imaging of lymph nodes during robotic-assisted laparoscopic operation for endometrial cancer. A prospective validation study using a sentinel lymph node surgical algorithm.
Hagen B; Valla M; Aune G; Ravlo M; Abusland AB; Araya E; Sundset M; Tingulstad S
Gynecol Oncol; 2016 Dec; 143(3):479-483. PubMed ID: 27776838
[TBL] [Abstract][Full Text] [Related]
20. Technetium-99m-indocyanine green versus technetium-99m-methylene blue for sentinel lymph node biopsy in early-stage endometrial cancer.
Cabrera S; Bebia V; Franco-Camps S; Forcada C; Villasboas-Rosciolesi D; Navales I; Pérez-Benavente A; Gil-Moreno A
Int J Gynecol Cancer; 2020 Mar; 30(3):311-317. PubMed ID: 31992599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
